Psychiatry

A recent study in China aligns with findings regarding lower life quality rankings for older adults.

New findings illuminate the need for clinicians to address sleep issues for patients with autism.

People with diabetes in Italy and the UK reported the highest rates of anxiety at 63% and 51%, respectively.

Dr. Reid Robison, MD, MBA, described his research on clinical depression and the recent acceptance of psychedelic medicine.

Suicidal ideation showed a significant effect in favor of family therapy compared to comparison therapy.

The results show pediatric patients with ADHD had a significantly higher risk of injuries requiring hospitalization compared to non-ADHD controls.

The investigators identified 4 distinct subgroups—earlier rising/robust, shorter active period/less modelable, shorter active period/very weak, and later settling/very weak.

Recent research from the National Psoriasis Foundation (NPF) found that 1 in 3 individuals living with psoriatic conditions experience depression.

Older participants had smaller dual-task performance deficits for gait and texting speed in both the ADHD group and the control group.

The mean daily alcohol consumption was also lower in the psilocybin group compared to the placebo group.

The results show 88.6% of participants had medium to high range emotion exhaustion, while 82.8% exhibited medium to high range depersonalization and 19.6% of patients had low to medium range personal accomplishment.

An Oakland-based analysis of mortality among homeless adults aged ≥50 years old illuminates the need for more proactive homeless care policies.

The cohort study is the first to report developmental cascades between disturbed sleep and depressive symptoms throughout childhood and early adolescence.

Treatment adherence remains a concern in psychiatry.

Multivariate dimensional association scores resulted in an overall increase and normalization with age in the ADHD.

Anhedonia had the highest expected influence in the most comprehensive network analysis, showing connections with negative and positive symptoms and functional domains.

The meta-analysis showed an increased odds ratio of developing postpartum depression when the maternal family had a history of psychiatric disorders.

Dextromethorphan HBr-bupropion HCI (Auvelity) is developed by Axsome Therapeutics.

The FDA approved esketamine in 2019 for major depressive disorder.

Postpartum depression rates have increased since the COVID-19 pandemic.

Alcohol, stress, drug use, and not seeking help are all risk factors for chronic depression.

CBD has shown promise in treating anxiety and psychosis.

There remains a need for better treatments for bipolar disorder when it is identified early.

Mixed feature depression can be difficult to diagnose because the symptoms can be similar to other psychiatric disorders.

There remains a need for more research into the connection between grief and depression following a death.